A Modified and Practical Surgical Technique for Pure Transperitoneal Laparoscopic Radical Nephroureterectomy in a Single Position and Research Outcomes

医学 外科 失血 围手术期 袖口 腹腔镜检查 病态的 远处转移 转移 癌症 内科学
作者
Qinxin Zhao,Liyuan Wu,Feiya Yang,Dong Chen,Nianzeng Xing
出处
期刊:Journal of Laparoendoscopic & Advanced Surgical Techniques [Mary Ann Liebert]
卷期号:33 (7): 691-697
标识
DOI:10.1089/lap.2022.0527
摘要

Purpose: To explore the surgical techniques and clinical value of pure transperitoneal laparoscopic nephroureterectomy (LNU) plus bladder cuff excision (BCE) conducted without changing the patient's position in the treatment of upper tract urothelial carcinoma (UTUC). Methods: From August 2018 to July 2021, we retrospectively reviewed 66 patients who underwent LNU + BCE in a single position. Then, their demographic characteristics, perioperative and pathological outcomes, and postoperative follow-up data were evaluated. Results: All 66 operations in this group were successfully completed without conversion to open surgery. The mean operative time was 125 ± 47 minutes, whereas the estimated blood loss was 10 (10, 15) mL. The median postoperative drainage time was 4 (3.8, 6.0) days, the time to catheter extraction after the operation was 4.5 (3.0, 6.0) days, and the median postoperative hospital stay was 6 (5, 7) days. Pathological results showed urothelial carcinoma in 65 cases, including 56 high-grade and 9 low-grade cases. Lymph node metastasis was found in 8 cases of high-grade urothelial carcinoma. All the surgical margins were negative. The median follow-up was 16.5 (11.0–25.6) months, and there was neither tumor recurrence nor distant metastasis. Conclusions: Pure transperitoneal LNU + BCE in a single position is a safe and effective minimally invasive technique for UTUC and is worthy of clinical application and promotion. It takes advantage of a programmed procedure, short operation time, less blood loss, less trauma, and quick recovery after the operation. However, multicenter randomized controlled studies with large samples are needed to further confirm these findings. Trial Registration: The study was registered at Cancer Hospital, Chinese Academy of Medical Sciences (No. 22/054-3255) and the registration date is August 2018.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
强砸完成签到,获得积分10
2秒前
顾矜应助曾经二娘采纳,获得10
3秒前
4秒前
大模型应助zero采纳,获得10
4秒前
俭朴尔竹发布了新的文献求助10
4秒前
ding应助圈圈采纳,获得10
6秒前
Owen应助笑点低小蚂蚁采纳,获得10
7秒前
7秒前
云白完成签到,获得积分10
7秒前
ranjiao驳回了Akim应助
10秒前
彭于晏应助卷卷516采纳,获得10
10秒前
qigao完成签到,获得积分10
11秒前
慕青应助momo采纳,获得10
11秒前
烟花应助此时此刻采纳,获得10
11秒前
Sin7完成签到,获得积分10
12秒前
欢喜素阴发布了新的文献求助10
12秒前
13秒前
zain完成签到 ,获得积分10
14秒前
共享精神应助海茵采纳,获得10
15秒前
16秒前
sisi完成签到,获得积分10
16秒前
Cherish完成签到,获得积分10
17秒前
18秒前
折旧完成签到,获得积分10
18秒前
19秒前
19秒前
徐徐徐徐完成签到 ,获得积分10
20秒前
曾经二娘发布了新的文献求助10
21秒前
lulu发布了新的文献求助30
22秒前
23秒前
共享精神应助科研通管家采纳,获得10
24秒前
田様应助科研通管家采纳,获得10
24秒前
爆米花应助科研通管家采纳,获得10
24秒前
爆米花应助科研通管家采纳,获得10
24秒前
烟花应助科研通管家采纳,获得10
24秒前
24秒前
劲秉应助科研通管家采纳,获得10
24秒前
小马甲应助科研通管家采纳,获得10
24秒前
24秒前
善学以致用应助Sin7采纳,获得10
26秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2500
Востребованный временем 2500
Aspects of Babylonian celestial divination : the lunar eclipse tablets of enuma anu enlil 1500
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 1000
Classics in Total Synthesis IV: New Targets, Strategies, Methods 1000
지식생태학: 생태학, 죽은 지식을 깨우다 600
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3458698
求助须知:如何正确求助?哪些是违规求助? 3053476
关于积分的说明 9036705
捐赠科研通 2742678
什么是DOI,文献DOI怎么找? 1504506
科研通“疑难数据库(出版商)”最低求助积分说明 695319
邀请新用户注册赠送积分活动 694494